Incidence of cancer in ANCA-associated vasculitis: A meta-analysis of observational studies

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Shang, Weifeng ^a   Ning, Yong ^a   Xu, Xiu ^a   Li, Menglan ^a   Guo, Shuiming ^a   Han, Min ^a   Zeng, Rui ^a   Ge, Shuwang ^a   Xu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ANCA ASSOCIATED VASCULITIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; COHORT ANALYSIS; COLON CANCER; COMORBIDITY; CONFIDENCE INTERVAL; GENETIC HETEROGENEITY; HUMAN; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; META ANALYSIS (TOPIC); NON MELANOMA SKIN CANCER; OBSERVATIONAL STUDY; POPULATION RESEARCH; PROSTATE CANCER; RISK ASSESSMENT; SYSTEMATIC REVIEW; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHEMICALLY INDUCED; COMPLICATION; INCIDENCE; META ANALYSIS; NEOPLASMS; SKIN NEOPLASMS; URINARY BLADDER NEOPLASMS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LEUKEMIA; NEOPLASMS; SKIN NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84929339537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126016     Document Type: Article

References (34)

1. Jennette JC, Falk RJ, Hu P Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8: 139-160. doi: 10.1146/annurev-pathol-011811-132453 PMID: 23347350
2. Scott DG, Watts RA (2013) Epidemiology and clinical features of systemic vasculitis. Clin Exp Nephrol 17: 607-610. doi: 10.1007/s10157-013-0830-8 PMID: 23843034
3. Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76-85 PMID: 6336643
4. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70: 488-494. doi: 10.1136/ard.2010.137778 PMID: 21109517
5. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U (2006) Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173: 180-187. doi: 10.1164/rccm.200507-1144OC PMID: 16224107
6. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488-498 PMID: 1739240
7. Berden A, Goceroglu A, Jayne D, Luqmani R, Rasmussen N, Bruijn JA, et al. (2012) Diagnosis and management of ANCA associated vasculitis. Bmj 344: e26. doi: 10.1136/bmj.e26 PMID: 22250224
8. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J (1998) Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9: 842-852 PMID: 9596082
9. Knight A, Askling J, Ekbom A (2002) Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer 100: 82-85. doi: 10.1002/ijc.10444 PMID: 12115591
10. Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N, et al. (2008) Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35: 100-105 PMID: 17937462
11. Heijl C, Harper L, Flossmann O, Stucker I, Scott DG, Watts RA, et al. (2011) Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials. Ann Rheum Dis 70: 1415-1421. doi: 10.1136/ard.2010.145250 PMID: 21616914
12. Zycinska K, Kostrzewa-Janicka J, Nitsch-Osuch A, Wardyn K (2013) Cancer incidence in pulmonary vasculitis. Adv Exp Med Biol 788: 349-353. doi: 10.1007/978-94-007-6627-3-47 PMID: 23835997
13. Silva F, Seo P, Schroeder DR, Stone JH, Merkel PA, Hoffman GS, et al. (2011) Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term follow-up of a multicenter longitudinal cohort. Arthritis Rheum 63: 2495-2503. doi: 10.1002/art.30394 PMID: 21484770
14. Holle JU, Gross WL, Latza U, Nolle B, Ambrosch P, Heller M, et al. (2011) Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63: 257-266. doi: 10.1002/art.27763 PMID: 20862686
15. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, et al. (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124: 477-484 PMID: 8602705
16. Mahr A, Heijl C, Le Guenno G, Faurschou M (2013) ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships. Best Pract Res Clin Rheumatol 27: 45-56. doi: 10.1016/j.berh.2012.12.003 PMID: 23507056
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283: 2008-2012 PMID: 10789670
18. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-605. doi: 10.1007/s10654-010-9491-z PMID: 20652370
19. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748 PMID: 13655060
20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188 PMID: 3802833
21. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. doi: 10.1002/sim.1186 PMID: 12111919
22. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101 PMID: 7786990
23. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634 PMID: 9310563
24. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA, et al. (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309: 1871-1874. doi: 10.1126/science.1114233 PMID: 16166520
25. Pedersen-Bjergaard J, Specht L, Larsen SO, Ersboll J, Struck J, Hansen MM, et al. (1987) Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 2: 83-88 PMID: 2885581
26. Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L (2011) Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 63: 1435-1445. doi: 10.1002/art.30296 PMID: 21337321
27. Monach PA, Arnold LM, Merkel PA (2010) Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum 62: 9-21. doi: 10.1002/art.25061 PMID: 20039416
28. Roussou M, Dimopoulos SK, Dimopoulos MA, Anastasiou-Nana MI (2008) Wegener's granulomatosis presenting as a renal mass. Urology 71: 547.e541-542. doi: 10.1016/j.urology.2007.11.046 PMID: 18342212
29. Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P, et al. (2007) High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 57: 619-625. doi: 10.1002/art.22667 PMID: 17471531
30. Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN (2014) Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. Ann Oncol 25: 16-23. doi: 10.1093/annonc/mdt372 PMID: 24310915
31. Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007) Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. Jama 298: 655-669. doi: 10.1001/jama.298.6.655 PMID: 17684188
32. Weyand CM, Goronzy JJ, Kurtin PJ (2006) Lymphoma in rheumatoid arthritis: an immune system set up for failure. Arthritis Rheum 54: 685-689. doi: 10.1002/art.21674 PMID: 16508924
33. Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165: 2337-2344. doi: 10.1001/archinte.165.20.2337 PMID: 16287762
34. Fortin PR (1996) Vasculitides associated with malignancy. Curr Opin Rheumatol 8: 30-33 PMID: 8867536